M. Chaneac

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

D. Dhumeaux, K. Reddy, D. Häussinger, 2005, Journal of hepatology.

Anticoagulant-induced preanalytical errors in ionized calcium determination on blood.

M. Déchaux, C. Kindermans, C. Sachs, 1989, Scandinavian journal of clinical and laboratory investigation.

Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a.

F. Negro, G. Leandro, F. Bonino, 1994, Gastroenterology.

Double‐blind, randomized controlled trial of interleukin‐2 treatment of chronic hepatitis B

G. Fattovich, A. Alberti, G. Giustina, 1998, Journal of medical virology.

[Early pregnancy interruption using an antiprogesterone steroid: Mifepristone (RU 486)].

B. Maria, A. Ulmann, M. Chaneac, 1988, Journal de gynecologie, obstetrique et biologie de la reproduction.

Use of calcium-titrated sodium heparinate for ionized calcium determination on plasma and whole blood (heparinized blood sampler B-129 Radiometer).

M. Déchaux, C. Kindermans, C. Sachs, 1991, Scandinavian journal of clinical and laboratory investigation.

Preanalytical Errors in Ionized Calcium Measurements Induced by the Use of Liquid Heparin

M. Déchaux, C. Kindermans, C. Sachs, 1991, Annals of clinical biochemistry.

189 Treatment of chronic hepatitis C with peginterferon ALFA-2A (40KD) (PEGASYS®) and ribavirin (COPEGUS®): patient age has a marked influence on the individual estimated probability of achieving a sustained virological response

G. Foster, S. Hadziyannis, M. Fried, 2003 .